TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Medi Caps Ltd.
MEDICAPQ

Medi Caps Ltd. Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 32/100 · Weak See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹25.08

Change

+0.09 (0.36%)

Open

₹25.2

Prev. Close

₹24.99

Day High

₹25.3

Day Low

₹24.6

Volume Analysis

Traded

2,022

Delivered

10,195

Delivery %

65.22%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (3)

  • •Low return on equity (-9.21%)
  • •Below-average fundamentals quality score (32/100)
  • •Low operating margin (-62.58%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹26.08 ₹25.69 ₹25.38 ₹24.99 ₹24.68 ₹24.29 ₹23.98
Fibonacci ₹25.69 ₹25.42 ₹25.26 ₹24.99 ₹24.72 ₹24.56 ₹24.29
Camarilla ₹25.27 ₹25.21 ₹25.14 ₹24.99 ₹25.02 ₹24.95 ₹24.89

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-3.24%

1 Month

-3.2%

3 Months

—

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

-1.61%

Net margin -14.17% × asset turnover 0.11x × equity multiplier 1.03x

Company Overview

Sector

Healthcare

Market Cap

₹31 Cr

ROE

-9.21%

Book Value

₹89.5

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.

TopFund Analysis

Medi Caps Ltd. scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 32/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (-9.21%); below-average fundamentals quality score (32/100).

TopFund Score — Fundamentals Quality

32/100 — Weak

Data confidence: 70/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

100

Growth

0

Valuation

14

Cash Flow

0

Corporate Governance

66

Momentum

20

Institutional Ownership

30

Business Quality

20

Liquidity

45

From Screener.in

  • +Company is almost debt free.
  • +Stock is trading at 0.28 times its book value
  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -26.3% over past five years.
  • −Company has a low return on equity of -4.34% over last 3 years.
  • −Company has high debtors of 203 days.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Announcements Under Regulation 30(LODR) 23 Sep

AGM approved reappointment of CMD Alok K Garg and appointment of Saloni Garg as whole-time woman director.

Voting Results Along With Scrutinizer"S Report Of 43Rd AGM 23 Sep 23 Sep
Shareholder Meeting / Postal Ballot-Outcome of AGM 22 Sep 22 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 27 Aug

Submission of News paper publication after dispatch of 43rd AGM Notice and Annual Report 2025-26.

Information Regarding E-Voting For 43Rd Annual General Meeting. 25 Aug

Medi-Caps Limited announces e-voting details for 43rd AGM on 22 September 2026, with three resolutions.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 6 6 7 8 6 8 4 7 3 2 4 3 3
Expenses + 7 6 6 8 6 8 6 7 6 5 5 6 5
Operating Profit -1 1 1 -1 0 0 -2 0 -3 -3 -1 -2 -2
OPM % -11.44% 8.29% 9.9% -6.35% -4.52% 5.43% -44.28% -3.3% -125.65% -144.06% -24.65% -59.71% -65.59%
Other Income + 0 0 0 0 0 0 0 2 0 2 1 6 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 1 0
Profit before tax -1 0 0 -1 -1 0 -2 1 -4 -2 -1 3 -2
Tax % 0.0% 0.0% 150.0% 83.05% 0.0% 0.0% 0.0% -18.62% 0.0% 0.0% 4.05% -0.33% 0.0%
Net Profit + -1 0 0 -1 -1 0 -2 2 -3 -2 -1 3 -2
EPS in Rs -1 0 0 -1 0 0 -2 1 -3 -1 -1 2 -2
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 36 43 44 54 52 43 57 70 49 27 25 12 13
Expenses + 36 40 42 52 47 50 46 60 44 27 27 22 20
Operating Profit 0 3 2 2 5 -7 11 10 5 0 -2 -9 -8
OPM % -0.22% 6.07% 3.66% 4.04% 9.11% -15.68% 19.1% 14.41% 10.51% 0.0% -7.06% -75.58% -62.58%
Other Income + 1 1 2 1 3 3 2 2 1 0 3 8 8
Interest 1 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2
Profit before tax -1 1 2 1 6 -6 11 10 5 -1 -1 -3 -2
Tax % 63.49% 39.16% 20.35% 14.81% 2.18% 0.17% -0.09% 0.1% 63.62% 80.0% -32.14% 0.66% —
Net Profit + -2 1 1 1 5 -6 11 10 2 -2 -1 -3 -2
EPS in Rs -2 1 1 1 4 -5 9 8 1 -2 0 -2 -1
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 69 70 77 78 83 78 92 104 106 109 109 99
Borrowings + 1 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities + 7 11 8 11 11 4 10 14 7 6 4 4
Total Liabilities 89 93 97 101 107 95 115 130 126 127 125 115
Fixed Assets + 58 56 62 61 60 57 58 59 59 59 57 56
CWIP 0 0 0 0 0 1 1 0 0 0 0 0
Investments 5 7 8 11 16 22 29 31 32 38 43 35
Other Assets + 26 30 27 29 30 15 27 40 35 30 25 24
Total Assets 89 93 97 101 107 95 115 130 126 127 125 115
Equity Capital 12 12 12 12 12 12 12 12 12 12 12 12

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 7 3 4 4 6 5 15 7 -6 7 5 -7
Cash from Investing Activity + -7 -1 3 -4 -6 -6 -10 -4 -3 -8 -5 7
Cash from Financing Activity + 0 -1 -6 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 1 0 0 -1 6 3 -9 -1 0 0
CFO/OP -9,750 120 270 202 128 -69 140 70 -58 — -267 74
Free Cash Flow 7 2 9 4 5 3 13 4 -7 7 5 -8

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 50.13% → 51.44%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 49.84% 49.85% 49.84% 49.83% 49.54% 49.35% 49.21% 49.21% 49.19% 49.21% 48.61% 48.54%
Promoters 50.13% 50.13% 50.13% 50.13% 50.42% 50.61% 50.76% 50.76% 50.76% 50.76% 51.36% 51.44%
DII 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02% 0.02%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Medi Caps Ltd. (this stock) 31 — 0.28 -9.21%
Gkb Ophthalmics Ltd. 36 9.69 0.66 3.28%
Vivo Bio Tech Ltd. 38 — 0.4 -2.0%
Vivimed Labs Limited 46 — -0.22 —
Ortin Global Limited 12 — — —
Mangalam Drug & Chem Ltd 50 — 0.49 -35.2%
Sunil Healthcare Ltd. 78 21.1 1.12 6.01%

Which Mutual Funds Hold Medi Caps Ltd.?

Frequently Asked Questions about Medi Caps Ltd.

Community Sentiment

What are other investors saying about Medi Caps Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.